Dr. Lal Path Labs Ltd. (LALPATHLAB)
Proceeding of the 32nd AGM is attached
Proceedings of the 32nd AGM held on July 25, 2026, through video conference. Key items: adoption of FY26 audited financials, final dividend of INR 4/share declared, re-appointment of Mr. Rahul Sharma as Director, and revisions in remuneration for Executive Chairman and Whole-Time Director. E-voting conducted with results to be announced by July 28, 2026.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 LALPATHLAB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add LALPATHLAB to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Dr. Lal Path Labs Ltd.
Important.
The summary above is generated automatically from Dr. Lal Path Labs Ltd.'s own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.